trending Market Intelligence /marketintelligence/en/news-insights/trending/TdE5CvKKHo9ksskhty2QYQ2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Summit Therapeutics CFO to resign


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Summit Therapeutics CFO to resign

Summit Therapeutics PLC said Erik Ostrowski would step down as CFO at the end of December.

"The company will appoint a new chief financial officer in due course," Summit Therapeutics said.

Abingdon, U.K.-based Summit Therapeutics is a biopharmaceutical company that focuses on the discovery, development and commercialization of novel medicines to treat rare and infectious diseases.